Apr 2022 Articles

Articles
Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis
Quispe R, Alfaddagh A, Kazzi B, et al.
Journal:
Curr Atheroscler Rep

First published: April 30, 2022 DOI: 10.1007/s11883-022-01031-9
View
- Share
Articles
Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis
Behrouzi B, Bhatt DL, Cannon CP, et al.
Journal:
JAMA Netw Open

First published: April 29, 2022 DOI: 10.1001/jamanetworkopen.2022.8873
View
- Share
Articles
The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl
Derington CG, Bress AP, Herrick JS, et al.
Journal:
Am J Prev Cardiol

First published: April 28, 2022 DOI: 10.1016/j.ajpc.2022.100345
View
- Share
Articles
Aspirin Use to Prevent Cardiovascular Disease – US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Journal:
JAMA

First published: April 26, 2022 DOI: 10.1001/jama.2022.4983
View
- Share
Articles
Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study
Mohammadi-Shemirani P, Chong M, Narula S, et al.
Journal:
J Am Coll Cardiol

First published: April 26, 2022 DOI: 10.1016/j.jacc.2022.02.018
View
- Share
Articles
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)
Ballantyne CM, Banach M, Bays HE, et al.
Journal:
Am J Cardiol

First published: April 26, 2022 DOI: 10.1016/j.amjcard.2022.03.020
View
- Share
Articles
Advancements in the Treatment of Homozygous Familial Hypercholesterolemia
Bajaj A, Cuchel M
Journal:
J Atheroscler Thromb

First published: April 24, 2022 DOI: 10.5551/jat.RV17065
View
- Share
Articles
Alirocumab after acute coronary syndrome in patients with a history of heart failure
White HD, Schwartz GG, Szarek M, et al.
Journal:
Eur Heart J

First published: April 21, 2022 DOI: 10.1093/eurheartj/ehab804
View
- Share
Articles
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis
Wang N, Woodward M, Huffman MD, et al.
Journal:
Circ Cardiovasc Qual Outcomes

First published: April 18, 2022 DOI: 10.1161/CIRCOUTCOMES.121.008552
View
- Share
Articles
Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study
Vasan RS, Enserro DM, Xanthakis V, et al.
Journal:
Circulation

First published: April 18, 2022 DOI: 10.1161/CIRCULATIONAHA.121.057889
View
- Share
Articles
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy
Toscano A, Cinquegrani M, Scuruchi M, et al.
Journal:
Biomolecules

First published: April 9, 2022 DOI: 10.3390/biom12040562
View
- Share
Articles
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial
Räber L, Ueki Y, Otsuka T, et al.
Journal:
JAMA

First published: April 3, 2022 DOI: 10.1001/jama.2022.5218
View
- Share

1 2

Apr 2022 Articles

Articles

Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis

Quispe R, Alfaddagh A, Kazzi B, et al.

Articles

Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis

Behrouzi B, Bhatt DL, Cannon CP, et al.

Articles

The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl

Derington CG, Bress AP, Herrick JS, et al.

Articles

Aspirin Use to Prevent Cardiovascular Disease – US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force

Articles

Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study

Mohammadi-Shemirani P, Chong M, Narula S, et al.

Articles

Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)

Ballantyne CM, Banach M, Bays HE, et al.

Articles

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

Bajaj A, Cuchel M

Articles

Alirocumab after acute coronary syndrome in patients with a history of heart failure

White HD, Schwartz GG, Szarek M, et al.

Articles

Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis

Wang N, Woodward M, Huffman MD, et al.

Articles

Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study

Vasan RS, Enserro DM, Xanthakis V, et al.

Articles

PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy

Toscano A, Cinquegrani M, Scuruchi M, et al.

Articles

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial

Räber L, Ueki Y, Otsuka T, et al.

Articles

Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis

Quispe R, Alfaddagh A, Kazzi B, et al.

Share

Articles

Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis

Behrouzi B, Bhatt DL, Cannon CP, et al.

Share

Articles

The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl

Derington CG, Bress AP, Herrick JS, et al.

Share

Articles

Aspirin Use to Prevent Cardiovascular Disease – US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force

Share

Articles

Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study

Mohammadi-Shemirani P, Chong M, Narula S, et al.

Share

Articles

Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)

Ballantyne CM, Banach M, Bays HE, et al.

Share

Articles

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

Bajaj A, Cuchel M

Share

Articles

Alirocumab after acute coronary syndrome in patients with a history of heart failure

White HD, Schwartz GG, Szarek M, et al.

Share

Articles

Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis

Wang N, Woodward M, Huffman MD, et al.

Share

Articles

Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study

Vasan RS, Enserro DM, Xanthakis V, et al.

Share

Articles

PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy

Toscano A, Cinquegrani M, Scuruchi M, et al.

Share

Articles

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial

Räber L, Ueki Y, Otsuka T, et al.

Share